tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market
XERS
Xeris Pharmaceuticals
RESEARCH TOOLSreports
Want to see XERS full AI Analyst Report?

Xeris Pharmaceuticals (XERS) Ratios

1,099 Followers

Xeris Pharmaceuticals Ratios

XERS's free cash flow for Q4 2025 was $0.78. For the 2025 fiscal year, XERS's free cash flow was decreased by $ and operating cash flow was $0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.19 2.19 1.67 1.64 2.54
Quick Ratio
 1.57 1.57 1.19 1.23 2.20
Cash Ratio
 1.01 1.01 0.71 0.71 1.66
Solvency Ratio
 0.04 0.03 -0.12 -0.15 -0.27
Operating Cash Flow Ratio
 0.26 0.26 -0.37 -0.49 -1.40
Short-Term Operating Cash Flow Coverage
 4.59 4.59 -2.45 0.00 0.00
Net Current Asset Value
$ -129.53M$ -129.53M$ -185.01M$ -173.12M$ -112.52M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 0.84 0.71 0.57
Debt-to-Equity Ratio
 2.76 2.76 -9.17 -33.79 4.38
Debt-to-Capital Ratio
 0.73 0.73 1.12 1.03 0.81
Long-Term Debt-to-Capital Ratio
 0.70 0.70 1.16 1.04 0.81
Financial Leverage Ratio
 28.02 28.02 -10.91 -47.57 7.62
Debt Service Coverage Ratio
 0.99 0.36 -0.24 -0.85 -4.81
Interest Coverage Ratio
 0.86 0.86 -1.01 -1.65 -5.81
Debt to Market Cap
 0.03 0.03 0.47 0.59 1.04
Interest Debt Per Share
 0.40 0.42 2.08 1.86 1.56
Net Debt to EBITDA
 -2.09 -5.77 -14.28 -6.81 -1.10
Profitability Margins
Gross Profit Margin
81.70%81.70%81.86%82.52%79.47%
EBIT Margin
7.70%0.19%-13.11%-22.51%-74.36%
EBITDA Margin
12.00%4.36%-6.89%-14.48%-62.87%
Operating Profit Margin
8.53%8.53%-16.57%-26.85%-74.32%
Pretax Profit Margin
0.19%0.19%-28.12%-38.74%-87.15%
Net Profit Margin
0.19%0.19%-27.00%-37.98%-85.86%
Continuous Operations Profit Margin
0.19%0.19%-27.00%-37.98%-85.86%
Net Income Per EBT
100.00%100.00%96.03%98.03%98.52%
EBT Per EBIT
2.23%2.23%169.72%144.29%117.26%
Return on Assets (ROA)
0.14%0.14%-16.97%-19.30%-27.48%
Return on Equity (ROE)
-5.33%4.05%185.16%917.94%-209.49%
Return on Capital Employed (ROCE)
9.09%9.09%-15.11%-19.35%-30.25%
Return on Invested Capital (ROIC)
8.89%8.89%-13.25%-18.68%-29.63%
Return on Tangible Assets
0.20%0.20%-27.24%-32.77%-47.08%
Earnings Yield
0.05%0.04%-11.02%-19.24%-52.48%
Efficiency Ratios
Receivables Turnover
 5.72 5.72 5.02 4.18 3.58
Payables Turnover
 17.36 17.36 16.08 2.48 4.91
Inventory Turnover
 0.78 0.78 0.76 0.74 0.92
Fixed Asset Turnover
 10.79 10.79 7.20 5.62 11.60
Asset Turnover
 0.76 0.76 0.63 0.51 0.32
Working Capital Turnover Ratio
 2.45 2.95 3.17 1.88 1.25
Cash Conversion Cycle
 512.11 512.11 527.36 434.80 426.67
Days of Sales Outstanding
 63.85 63.85 72.64 87.28 102.07
Days of Inventory Outstanding
 469.29 469.29 477.41 494.88 398.88
Days of Payables Outstanding
 21.02 21.02 22.69 147.36 74.28
Operating Cycle
 533.14 533.14 550.05 582.16 500.95
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 0.18 -0.25 -0.34 -0.76
Free Cash Flow Per Share
 0.23 0.17 -0.26 -0.36 -0.76
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 <0.01
Free Cash Flow to Operating Cash Flow
 1.32 0.98 1.02 1.05 1.01
Dividend Paid and CapEx Coverage Ratio
 41.13 41.13 -42.60 -20.78 -196.36
Capital Expenditure Coverage Ratio
 41.13 41.13 -42.60 -20.78 -196.36
Operating Cash Flow Coverage Ratio
 0.76 0.76 -0.14 -0.21 -0.52
Operating Cash Flow to Sales Ratio
 0.10 0.10 -0.18 -0.29 -0.93
Free Cash Flow Yield
3.46%2.22%-7.61%-15.23%-57.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 1.90K 2.27K -9.07 -5.20 -1.91
Price-to-Sales (P/S) Ratio
 3.74 4.32 2.45 1.97 1.64
Price-to-Book (P/B) Ratio
 76.72 92.00 -16.80 -47.71 3.99
Price-to-Free Cash Flow (P/FCF) Ratio
 28.88 45.09 -13.15 -6.56 -1.74
Price-to-Operating Cash Flow Ratio
 36.69 43.99 -13.45 -6.88 -1.75
Price-to-Earnings Growth (PEG) Ratio
 5.16 -22.52 0.51 0.15 0.03
Price-to-Fair Value
 76.72 92.00 -16.80 -47.71 3.99
Enterprise Value Multiple
 29.06 93.32 -49.83 -20.45 -3.70
Enterprise Value
 1.02B 1.19B 697.39M 485.28M 256.48M
EV to EBITDA
 29.12 93.32 -49.83 -20.45 -3.70
EV to Sales
 3.49 4.06 3.43 2.96 2.33
EV to Free Cash Flow
 27.00 42.47 -18.43 -9.85 -2.48
EV to Operating Cash Flow
 35.63 41.43 -18.86 -10.32 -2.49
Tangible Book Value Per Share
 -0.59 -0.61 -1.03 -1.01 -0.72
Shareholders’ Equity Per Share
 0.08 0.09 -0.20 -0.05 0.33
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.04 0.02 0.01
Revenue Per Share
 1.76 1.82 1.38 1.19 0.81
Net Income Per Share
 <0.01 <0.01 -0.37 -0.45 -0.70
Tax Burden
 1.00 1.00 0.96 0.98 0.99
Interest Burden
 0.02 1.00 2.15 1.72 1.17
Research & Development to Revenue
 0.11 0.11 0.13 0.14 0.19
SG&A to Revenue
 0.62 0.62 0.81 0.00 0.00
Stock-Based Compensation to Revenue
 0.08 0.08 0.09 0.07 0.11
Income Quality
 51.67 51.67 0.67 0.76 1.09
Currency in USD